Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07019571 · ClinicalTrials.gov registry record · NA
tDCS and Urge in BFRBs
A NA study of Repetitive Compulsive Behavior, sponsored by Gopalkumar Rakesh.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT07019571: Recruiting NA study of Repetitive Compulsive Behavior, sponsored by Gopalkumar Rakesh.
NCT07019571 is a NA study of Repetitive Compulsive Behavior that is actively recruiting participants, run by Gopalkumar Rakesh. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07019571, a NA study of Repetitive Compulsive Behavior, is actively recruiting participants, sponsored by Gopalkumar Rakesh.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to find out if brain stimulation can help people stop skin-picking or nail-biting. The study wants to answer two main questions: 1. Does brain stimulation reduce the urge to pick skin or bite nails after those urges are triggered? 2. Does brain stimulation reduce how often people pick their skin or bite their nails? Participants will: * Talk about their skin-picking, nail-biting, and other mental health concerns * Be placed in situations that make them want to pick or bite * Rate how strong their urges are before and after brain stimulation Researchers will compare real brain stimulation to a placebo (a fake version that looks the same but has no effect) to see if the real stimulation works to reduce skin-picking and nail-biting urges and behaviors.
Primary Outcome
Individuals will rate their urge to pick using a scale (1-10) with a higher score meaning greater urge. They will rate their urge three times in a row, at two different time-points.
Conditions Studied
Interventions
- DEVICE Wireless Multichannel Transcranial Current Stimulator (tDCS)
- BEHAVIORAL Cue exposure
- BEHAVIORAL Boredom induction
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2025-07-08 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07019571 shows while recruiting
NCT07019571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Repetitive Compulsive Behavior appearing as the primary indexed condition, and to 3 interventions - of which Wireless Multichannel Transcranial Current Stimulator (tDCS) is the first listed.
NCT07019571 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07019571 about?
NCT07019571 is a clinical study titled "tDCS and Urge in BFRBs". The goal of this study is to find out if brain stimulation can help people stop skin-picking or nail-biting. The study wants to answer two main questions: 1. Does brain stimulation reduce the urge to pick skin or bite nails after those urges are triggered? 2. Does brain stimulation reduce how often...
What is the current status of trial NCT07019571?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2025-07-08. Estimated completion is 2026-05.
What conditions does trial NCT07019571 study?
This clinical trial studies the following conditions: Repetitive Compulsive Behavior.
What interventions are being tested in trial NCT07019571?
The interventions under investigation include: Wireless Multichannel Transcranial Current Stimulator (tDCS) (DEVICE), Cue exposure (BEHAVIORAL), Boredom induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT07019571?
This trial is sponsored by Gopalkumar Rakesh, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07019571 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Repetitive Compulsive Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07019571's enrollment target sits among peer trials
55 1265th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI